Live news related to MEDINCELL stock (FR0004065605): press releases, earnings publications, share price moves, analyst notes and corporate events. This page is auto-updated whenever new financial information is available.
At midday on Friday, December 12, 2025, Medincell's stock price has fallen 3.91% from the previous day, amidst limited trading volumes and following a…
The biopharmaceutical company's stock crossed the 28 euros mark this Wednesday, December 10, at midday, driven by the publication of increased semi-an…
The biopharmaceutical company's stock closed at 27.50 euros this Wednesday, December 10, continuing its upward trend that began earlier in the week. T…
Teva Pharmaceuticals, in partnership with Medincell, has submitted an application to the FDA for the approval of Olanzapine LAI, intended for the trea…
Medincell has announced a 50% increase in its operating income for the first half of the fiscal year 2025-2026, reaching 14.1 million euros.
The share price of the Montpellier-based biotech company MEDINCELL fell by 3.64% on Thursday, November 27, closing at 28.06 euros compared to 29.12 eu…
Medincell has announced its participation in two major conferences in December.
Medincell has announced receiving a $3 million grant from the Gates Foundation for its mdc-STM program, aimed at combating malaria.
Medincell stock experienced a clear correction phase over the week, aligning with a generally downward-oriented stock market context. Its annual perfo…
